Published in Science on August 11, 2000
MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number. Neuron (2007) 4.15
Integrated brain circuits: astrocytic networks modulate neuronal activity and behavior. Annu Rev Physiol (2010) 3.38
Antidepressant actions of histone deacetylase inhibitors. J Neurosci (2009) 3.17
Glutamatergic afferents of the ventral tegmental area in the rat. J Neurosci (2007) 2.80
The identification of vesicular glutamate transporter 3 suggests novel modes of signaling by glutamate. Proc Natl Acad Sci U S A (2002) 2.77
Vesicular glutamate transport promotes dopamine storage and glutamate corelease in vivo. Neuron (2010) 2.75
Glutamatergic neurons are present in the rat ventral tegmental area. Eur J Neurosci (2007) 2.53
Metabolic control of vesicular glutamate transport and release. Neuron (2010) 2.44
An essential role for vesicular glutamate transporter 1 (VGLUT1) in postnatal development and control of quantal size. Proc Natl Acad Sci U S A (2004) 2.26
Pedunculopontine and laterodorsal tegmental nuclei contain distinct populations of cholinergic, glutamatergic and GABAergic neurons in the rat. Eur J Neurosci (2009) 2.11
The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention. Neurochem Int (2007) 2.11
The Concise Guide to PHARMACOLOGY 2013/14: transporters. Br J Pharmacol (2013) 2.07
Vesicular glutamate transport at a central synapse limits the acuity of visual perception in zebrafish. Neuron (2007) 1.96
Palmitoylation-dependent neurodevelopmental deficits in a mouse model of 22q11 microdeletion. Nat Neurosci (2008) 1.92
Synaptic transmission at retinal ribbon synapses. Prog Retin Eye Res (2005) 1.85
Amino acid transporters: roles in amino acid sensing and signalling in animal cells. Biochem J (2003) 1.84
Molecular targets for antiepileptic drug development. Neurotherapeutics (2007) 1.78
Projections from basal forebrain to prefrontal cortex comprise cholinergic, GABAergic and glutamatergic inputs to pyramidal cells or interneurons. Eur J Neurosci (2008) 1.74
Organic anion transport is the primary function of the SLC17/type I phosphate transporter family. Pflugers Arch (2003) 1.71
Astrocyte signaling controls spike timing-dependent depression at neocortical synapses. Nat Neurosci (2012) 1.56
Mice lacking brain/kidney phosphate-activated glutaminase have impaired glutamatergic synaptic transmission, altered breathing, disorganized goal-directed behavior and die shortly after birth. J Neurosci (2006) 1.55
Neurotransmitter corelease: mechanism and physiological role. Annu Rev Physiol (2011) 1.52
Vesicular glutamate transporter 2 is required for the respiratory and parasympathetic activation produced by optogenetic stimulation of catecholaminergic neurons in the rostral ventrolateral medulla of mice in vivo. Eur J Neurosci (2013) 1.48
Specific regulation of NRG1 isoform expression by neuronal activity. J Neurosci (2011) 1.46
C. elegans feeding. WormBook (2012) 1.42
Vesicular glutamate transporter 3 expression identifies glutamatergic amacrine cells in the rodent retina. J Comp Neurol (2004) 1.41
The zinc transporter ZnT3 interacts with AP-3 and it is preferentially targeted to a distinct synaptic vesicle subpopulation. Mol Biol Cell (2003) 1.40
A chloride conductance in VGLUT1 underlies maximal glutamate loading into synaptic vesicles. Nat Neurosci (2009) 1.39
Touch sensitivity in Caenorhabditis elegans. Pflugers Arch (2007) 1.38
C. elegans G protein regulator RGS-3 controls sensitivity to sensory stimuli. Neuron (2007) 1.36
Molecular cloning and functional characterization of human vesicular glutamate transporter 3. EMBO Rep (2002) 1.35
Telencephalic neurons monosynaptically link brainstem and forebrain premotor networks necessary for song. J Neurosci (2008) 1.34
Glutamate forward and reverse transport: from molecular mechanism to transporter-mediated release after ischemia. IUBMB Life (2008) 1.30
Axonal motility and its modulation by activity are branch-type specific in the intact adult cerebellum. Neuron (2007) 1.28
Innervation of orexin/hypocretin neurons by GABAergic, glutamatergic or cholinergic basal forebrain terminals evidenced by immunostaining for presynaptic vesicular transporter and postsynaptic scaffolding proteins. J Comp Neurol (2006) 1.23
Functional annotation of the human retinal pigment epithelium transcriptome. BMC Genomics (2009) 1.22
VGLUT2 in dopamine neurons is required for psychostimulant-induced behavioral activation. Proc Natl Acad Sci U S A (2009) 1.21
Bidirectional regulation of thermotaxis by glutamate transmissions in Caenorhabditis elegans. EMBO J (2011) 1.17
Clustered burst firing in FMR1 premutation hippocampal neurons: amelioration with allopregnanolone. Hum Mol Genet (2012) 1.15
Regulation of mouse embryonic stem cell neural differentiation by retinoic acid. Dev Biol (2009) 1.14
Functional implications of glutamatergic projections to the ventral tegmental area. Rev Neurosci (2008) 1.11
Extrinsic afferent systems to the dentate gyrus. Prog Brain Res (2007) 1.09
Glutamate co-transmission as an emerging concept in monoamine neuron function. J Psychiatry Neurosci (2004) 1.09
Altered vesicular glutamate transporter expression in the anterior cingulate cortex in schizophrenia. Biol Psychiatry (2007) 1.09
Enriched expression of serotonin 1B and 2A receptor genes in macaque visual cortex and their bidirectional modulatory effects on neuronal responses. Cereb Cortex (2008) 1.08
Synaptic vesicle protein trafficking at the glutamate synapse. Neuroscience (2008) 1.06
Mitochondrial signals in glucose-stimulated insulin secretion in the beta cell. J Physiol (2000) 1.04
Expression of glutamate and inhibitory amino acid vesicular transporters in the rodent auditory brainstem. J Comp Neurol (2011) 1.03
Genetic inactivation of the vesicular glutamate transporter 2 (VGLUT2) in the mouse: what have we learnt about functional glutamatergic neurotransmission? Ups J Med Sci (2010) 1.03
Vesicular and plasma membrane transporters for neurotransmitters. Cold Spring Harb Perspect Biol (2012) 1.02
Dual regulation of Ca2+-dependent glutamate release from astrocytes: vesicular glutamate transporters and cytosolic glutamate levels. Glia (2009) 1.01
Comparison of the ontogeny of the vesicular glutamate transporter 3 (VGLUT3) with VGLUT1 and VGLUT2 in the rat retina. Brain Res (2008) 0.99
Vesicular glutamate (VGlut), GABA (VGAT), and acetylcholine (VACht) transporters in basal forebrain axon terminals innervating the lateral hypothalamus. J Comp Neurol (2006) 0.99
Candidate glutamatergic neurons in the visual system of Drosophila. PLoS One (2011) 0.98
The role of endocytosis in regulating the strength of hippocampal synapses. J Physiol (2008) 0.98
Docking and homology modeling explain inhibition of the human vesicular glutamate transporters. Protein Sci (2007) 0.98
Glutamate as a neurotransmitter in the healthy brain. J Neural Transm (Vienna) (2014) 0.97
Glutamate acts as a key signal linking glucose metabolism to incretin/cAMP action to amplify insulin secretion. Cell Rep (2014) 0.97
Altered expression of vesicular glutamate transporters VGLUT1 and VGLUT2 in Parkinson disease. Neurobiol Aging (2006) 0.97
Cortical expression of glial fibrillary acidic protein and glutamine synthetase is decreased in schizophrenia. Schizophr Res (2008) 0.96
Clathrin-mediated endocytosis is required for compensatory regulation of GLR-1 glutamate receptors after activity blockade. Proc Natl Acad Sci U S A (2004) 0.96
Quantitative analysis of glutamatergic innervation of the mouse dorsal raphe nucleus using array tomography. J Comp Neurol (2011) 0.95
Differential expression of vesicular glutamate transporters 1 and 2 may identify distinct modes of glutamatergic transmission in the macaque visual system. J Chem Neuroanat (2013) 0.95
Regulation of distinct attractive and aversive mechanisms mediating benzaldehyde chemotaxis in Caenorhabditis elegans. Learn Mem (2001) 0.95
Thiamine pyrophosphate biosynthesis and transport in the nematode Caenorhabditis elegans. Genetics (2004) 0.94
Assessment of the potential role of muscle spindle mechanoreceptor afferents in chronic muscle pain in the rat masseter muscle. PLoS One (2010) 0.94
Glutamatergic abnormalities of the thalamus in schizophrenia: a systematic review. J Neural Transm (Vienna) (2008) 0.93
Multiple dileucine-like motifs direct VGLUT1 trafficking. J Neurosci (2013) 0.93
Two populations of glutamatergic axons in the rat dorsal raphe nucleus defined by the vesicular glutamate transporters 1 and 2. Eur J Neurosci (2005) 0.93
Deletion of the NR2A subunit prevents developmental changes of NMDA-mEPSCs in cultured mouse cerebellar granule neurones. J Physiol (2005) 0.92
Update on the neurobiology of schizophrenia: a role for extracellular microdomains. Minerva Psichiatr (2012) 0.91
Retinal input regulates the timing of corticogeniculate innervation. J Neurosci (2013) 0.91
Rax is a selector gene for mediobasal hypothalamic cell types. J Neurosci (2013) 0.90
Target- and input-dependent organization of AMPA and NMDA receptors in synaptic connections of the cochlear nucleus. J Comp Neurol (2014) 0.90
The interplay between inorganic phosphate and amino acids determines zinc solubility in brain slices. J Neurochem (2009) 0.89
Vesicular glutamate transporter 1 is required for photoreceptor synaptic signaling but not for intrinsic visual functions. J Neurosci (2007) 0.89
Brainstem origins of glutamatergic innervation of the rat hypothalamic paraventricular nucleus. J Comp Neurol (2012) 0.89
Synaptic vesicle-bound pyruvate kinase can support vesicular glutamate uptake. Neurochem Res (2008) 0.89
Glutamatergic alterations in the cortex of genetic absence epilepsy rats. BMC Neurosci (2007) 0.88
Mechanisms of excitation of spinal networks by stimulation of the ventral roots. Ann N Y Acad Sci (2010) 0.88
Characterization of a protein of the plastid inner envelope having homology to animal inorganic phosphate, chloride and organic-anion transporters. Planta (2003) 0.88
Transcript expression of vesicular glutamate transporters in lumbar dorsal root ganglia and the spinal cord of mice - effects of peripheral axotomy or hindpaw inflammation. Neuroscience (2013) 0.87
Distinct Fos-Expressing Neuronal Ensembles in the Ventromedial Prefrontal Cortex Mediate Food Reward and Extinction Memories. J Neurosci (2016) 0.87
Abnormal expression of glutamate transporters in temporal lobe areas in elderly patients with schizophrenia. Schizophr Res (2013) 0.86
Creatine supplementation lowers brain glutamate levels in Huntington's disease. J Neurol (2005) 0.86
Vesicular glutamate transporter 1 immunoreactivity in extrinsic and intrinsic innervation of the rat esophagus. Histochem Cell Biol (2005) 0.86
VGLUTs in Peripheral Neurons and the Spinal Cord: Time for a Review. ISRN Neurol (2013) 0.85
A helper virus-free HSV-1 vector containing the vesicular glutamate transporter-1 promoter supports expression preferentially in VGLUT1-containing glutamatergic neurons. Brain Res (2010) 0.85
A population of glomerular glutamatergic neurons controls sensory information transfer in the mouse olfactory bulb. Nat Commun (2014) 0.85
Wnt and EGF pathways act together to induce C. elegans male hook development. Dev Biol (2008) 0.85
Synaptic vesicles are capable of synthesizing the VGLUT substrate glutamate from α-ketoglutarate for vesicular loading. J Neurochem (2012) 0.84
The vesicular monoamine transporter 2: an underexplored pharmacological target. Neurochem Int (2014) 0.84
Expression of vesicular glutamate transporters type 1 and 2 in sensory and autonomic neurons innervating the mouse colorectum. J Comp Neurol (2011) 0.84
Genetically encoded fluorescent sensors for studying healthy and diseased nervous systems. Drug Discov Today Dis Models (2008) 0.83
Quantal amplitude at the cone ribbon synapse can be adjusted by changes in cytosolic glutamate. Mol Vis (2011) 0.83
The vesicular glutamate transporter-1 upstream promoter and first intron each support glutamatergic-specific expression in rat postrhinal cortex. Brain Res (2010) 0.83
Co-localization of corticotropin-releasing factor and vesicular glutamate transporters within axon terminals of the rat dorsal raphe nucleus. Brain Res (2007) 0.83
Characterization of the transporterB0AT3 (Slc6a17) in the rodent central nervous system. BMC Neurosci (2013) 0.83
Combination of methamphetamine and HIV-1 gp120 causes distinct long-term alterations of behavior, gene expression, and injury in the central nervous system. Exp Neurol (2014) 0.83
A report--chronic fatigue syndrome: guidelines for research. J R Soc Med (1991) 7.70
The expression of vesicular glutamate transporters defines two classes of excitatory synapse. Neuron (2001) 4.97
Human skeletal muscle function: description of tests and normal values. Clin Sci Mol Med (1977) 4.71
Cloning of the cellular receptor for amphotropic murine retroviruses reveals homology to that for gibbon ape leukemia virus. Proc Natl Acad Sci U S A (1994) 4.67
Predicted normal values for maximal respiratory pressures in caucasian adults and children. Thorax (1984) 4.42
Identification and characterization of the vesicular GABA transporter. Nature (1997) 4.26
An increasing work rate test for assessing the physiological strain of submaximal exercise. Clin Sci Mol Med (1974) 3.73
Implications of socio-cultural contexts for the ethics of clinical trials. Health Technol Assess (1997) 3.57
Cloning of a delta opioid receptor by functional expression. Science (1992) 3.49
An analysis of the physiological strain of submaximal exercise in patients with chronic obstructive bronchitis. Thorax (1975) 3.13
Fatigue of long duration in human skeletal muscle after exercise. J Physiol (1977) 2.98
Ultrastructural changes after concentric and eccentric contractions of human muscle. J Neurol Sci (1983) 2.86
Cloning and expression of a functional serotonin transporter from rat brain. Nature (1991) 2.86
The vesicular GABA transporter, VGAT, localizes to synaptic vesicles in sets of glycinergic as well as GABAergic neurons. J Neurosci (1998) 2.76
A cDNA that suppresses MPP+ toxicity encodes a vesicular amine transporter. Cell (1992) 2.58
Muscle protein synthesis measured by stable isotope techniques in man: the effects of feeding and fasting. Clin Sci (Lond) (1982) 2.53
Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice. Proc Natl Acad Sci U S A (1998) 2.49
Normal muscle strength and fatigability in patients with effort syndromes. BMJ (1988) 2.46
bcl-2 inhibits death of central neural cells induced by multiple agents. Proc Natl Acad Sci U S A (1993) 2.39
Expression of a putative vesicular acetylcholine transporter facilitates quantal transmitter packaging. Neuron (1997) 2.37
Molecular cloning and expression of the cDNA for a novel alpha 1-adrenergic receptor subtype. J Biol Chem (1990) 2.35
The synaptic vesicle protein SV2 is a novel type of transmembrane transporter. Cell (1992) 2.25
Pain and fatigue after concentric and eccentric muscle contractions. Clin Sci (Lond) (1983) 2.24
Implantation metastasis as a cause of local recurrence of colorectal carcinoma. Am J Surg (1989) 2.11
Components of a calmodulin-dependent protein kinase cascade. Molecular cloning, functional characterization and cellular localization of Ca2+/calmodulin-dependent protein kinase kinase beta. J Biol Chem (1998) 2.10
Mammalian homologs of Drosophila ELAV localized to a neuronal subset can bind in vitro to the 3' UTR of mRNA encoding the Id transcriptional repressor. J Neurosci (1994) 2.09
Screening a large reference sample to identify very low frequency sequence variants: comparisons between two genes. Nat Genet (2001) 2.07
Clinical use of nuclear magnetic resonance in the investigation of myopathy. Lancet (1982) 2.02
Metabolic changes associated with the slowing of relaxation in fatigued mouse muscle. J Physiol (1975) 1.95
Exertion of stairclimbing in normal subjects and in patients with chronic obstructive bronchitis. Thorax (1977) 1.92
Vesicular transport regulates monoamine storage and release but is not essential for amphetamine action. Neuron (1997) 1.83
Randomised controlled trial of patient education to encourage graded exercise in chronic fatigue syndrome. BMJ (2001) 1.82
Synaptic vesicle transporter expression regulates vesicle phenotype and quantal size. J Neurosci (2000) 1.81
Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles. Proc Natl Acad Sci U S A (2000) 1.81
Molecular analysis of system N suggests novel physiological roles in nitrogen metabolism and synaptic transmission. Cell (1999) 1.79
The time course of phosphorylcreatine resynthesis during recovery of the quadriceps muscle in man. Pflugers Arch (1976) 1.78
Transthyretin: a choroid plexus-specific transport protein in human brain. The 1986 S. Weir Mitchell award. Neurology (1986) 1.78
Large delayed plasma creatine kinase changes after stepping exercise. Muscle Nerve (1983) 1.76
Molecular cloning and expression of the gene for a human D1 dopamine receptor. Nature (1990) 1.75
Differential expression of two vesicular monoamine transporters. J Neurosci (1995) 1.75
Central and peripheral fatigue in sustained maximum voluntary contractions of human quadriceps muscle. Clin Sci Mol Med (1978) 1.74
Practical problems in the respiratory care of patients with muscular dystrophy. N Engl J Med (1987) 1.74
Dendritic location of neural BC1 RNA. Proc Natl Acad Sci U S A (1991) 1.73
Percutaneous needle-biopsy of skeletal muscle in diagnosis and research. Lancet (1971) 1.72
Conchotome and needle percutaneous biopsy of skeletal muscle. J Neurol Neurosurg Psychiatry (1987) 1.72
Effect of temperature on muscle energy metabolism and endurance during successive isometric contractions, sustained to fatigue, of the quadriceps muscle in man. J Physiol (1972) 1.68
Excitation frequency and muscle fatigue: mechanical responses during voluntary and stimulated contractions. Exp Neurol (1979) 1.68
Sequence variation in the Epstein-Barr virus latent membrane protein 1. J Gen Virol (1994) 1.67
Repeatability of physical signs in airways obstruction. Thorax (1969) 1.65
Hypoxemia during sleep in Duchenne muscular dystrophy. Am Rev Respir Dis (1988) 1.63
The localization of the brain-specific inorganic phosphate transporter suggests a specific presynaptic role in glutamatergic transmission. J Neurosci (1998) 1.58
Nocturnal oxygenation and prognosis in Duchenne muscular dystrophy. Am J Respir Crit Care Med (1999) 1.54
Ultrastructural localization of the vesicular monoamine transporter-2 in midbrain dopaminergic neurons: potential sites for somatodendritic storage and release of dopamine. J Neurosci (1996) 1.52
Transient developmental expression of monoamine transporters in the rodent forebrain. J Comp Neurol (1998) 1.48
Electron spin resonance studies of intact mammalian skeletal muscle. Biochim Biophys Acta (1985) 1.48
Myositis ossificans non-progressiva--reversible muscle calcification in polymyositis. Br J Rheumatol (1989) 1.47
Sulfur revisited. J Am Acad Dermatol (1988) 1.46
Exercise performance and fatiguability in patients with chronic fatigue syndrome. J Neurol Neurosurg Psychiatry (1993) 1.45
Intravenous magnesium loading in chronic fatigue syndrome. Lancet (1992) 1.44
Hand-held dynamometer for evaluating voluntary-muscle function. Lancet (1974) 1.44
The gating of nucleotide-sensitive K+ channels in insulin-secreting cells can be modulated by changes in the ratio ATP4-/ADP3- and by nonhydrolyzable derivatives of both ATP and ADP. J Membr Biol (1988) 1.44
The role of vesicular transport proteins in synaptic transmission and neural degeneration. Annu Rev Neurosci (1997) 1.42
Distribution of alpha 2-adrenergic receptor subtype gene expression in rat brain. Brain Res Mol Brain Res (1994) 1.41
Human muscle function and fatigue. Ciba Found Symp (1981) 1.41
Cloning, molecular characterization, and chromosomal assignment of a gene encoding a second D1 dopamine receptor subtype: differential expression pattern in rat brain compared with the D1A receptor. Proc Natl Acad Sci U S A (1991) 1.40
Plasma creatine kinase changes after eccentric and concentric contractions. Muscle Nerve (1986) 1.40
Muscle strength and pre-osteomalacia in vegetarian Asian women. Lancet (1982) 1.39
Muscle relaxation rate, fibre-type composition and energy turnover in hyper- and hypo-thyroid patients. Clin Sci (Lond) (1979) 1.38
Subcellular localization and molecular topology of the dopamine transporter in the striatum and substantia nigra. J Comp Neurol (1997) 1.38
Expression of the putative vesicular acetylcholine transporter in rat brain and localization in cholinergic synaptic vesicles. J Neurosci (1996) 1.36
The chromaffin granule and synaptic vesicle amine transporters differ in substrate recognition and sensitivity to inhibitors. J Biol Chem (1994) 1.35
Mechanism for transcriptional gain of function resulting from chromosomal translocation in alveolar rhabdomyosarcoma. Proc Natl Acad Sci U S A (1996) 1.34
Physiological analysis of skeletal muscle weakness and fatigue. Clin Sci Mol Med (1978) 1.33
Exercise tolerance in chronic airway obstruction. Am Rev Respir Dis (1971) 1.33
Differential RNA splicing predicts two distinct nerve growth factor precursors. Nature (1986) 1.31
Heat production and chemical changes during isometric contractions of the human quadriceps muscle. J Physiol (1975) 1.30
Effect of exercise on protein turnover in man. Clin Sci (Lond) (1981) 1.29
Physiological correlates of perceived exertion in continuous and intermittent exercise with the same average power output. Eur J Clin Invest (1972) 1.28
The protooncogene bcl-2 inhibits apoptosis in PC12 cells. J Neurochem (1993) 1.28
Effects of Duchenne muscular dystrophy on muscle protein synthesis. Nature (1982) 1.28
Distinct spatial localization of specific mRNAs in cultured sympathetic neurons. Neuron (1990) 1.27
Muscle breakdown and repair in polymyositis: a case study. Muscle Nerve (1980) 1.27
31P-NMR studies of a human tumour in situ. Lancet (1983) 1.27
Muscle fatigue and pain. Acta Med Scand Suppl (1986) 1.26
Protein synthesis in muscle measured in vivo in cachectic patients with cancer. Br Med J (Clin Res Ed) (1984) 1.26
Measurements of muscle strength and performance in children with normal and diseased muscle. Arch Dis Child (1976) 1.26
Experimental mouse muscle damage: the importance of external calcium. Clin Sci (Lond) (1984) 1.26
Amino acid transport system A resembles system N in sequence but differs in mechanism. Proc Natl Acad Sci U S A (2000) 1.26
Improving outpatient clinic efficiency using computer simulation. Int J Health Care Qual Assur Inc Leadersh Health Serv (1997) 1.26
Needle biopsy for muscle chemistry. Lancet (1975) 1.25
Objective quantification of muscle and fat in human dystrophic muscle by magnetic resonance image analysis. Muscle Nerve (1996) 1.25
Changes in spirometry over time as a prognostic marker in patients with Duchenne muscular dystrophy. Am J Respir Crit Care Med (2001) 1.24
Occult ischaemic necrosis of skeletal muscle associated with renal failure. BMJ (1990) 1.24
Gene transfer of a reserpine-sensitive mechanism of resistance to N-methyl-4-phenylpyridinium. Proc Natl Acad Sci U S A (1992) 1.23
Size and composition of the calf and quadriceps muscles in Duchenne muscular dystrophy. A tomographic and histochemical study. J Neurol Sci (1983) 1.23
Effects of propranolol on response to exercise in hypertrophic obstructive cardiomyopathy. Br Heart J (1970) 1.23